Addus HomeCare Stock Forecast, Price & News

-0.22 (-0.26 %)
(As of 06/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume171,102 shs
Average Volume93,797 shs
Market Capitalization$1.34 billion
P/E Ratio40.46
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ADUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

Addus HomeCare logo

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of March 9, 2021, the company served consumers through 212 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.03 out of 5 stars

Medical Sector

77th out of 2,100 stocks

Home Health Care Services Industry

5th out of 12 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Addus HomeCare (NASDAQ:ADUS) Frequently Asked Questions

Is Addus HomeCare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Addus HomeCare stock.
View analyst ratings for Addus HomeCare
or view top-rated stocks.

What stocks does MarketBeat like better than Addus HomeCare?

Wall Street analysts have given Addus HomeCare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Addus HomeCare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Addus HomeCare's next earnings date?

Addus HomeCare is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Addus HomeCare

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) released its quarterly earnings data on Sunday, May, 2nd. The company reported $0.74 earnings per share for the quarter, hitting analysts' consensus estimates of $0.74. The business had revenue of $205.30 million for the quarter, compared to analysts' expectations of $209.70 million. Addus HomeCare had a net margin of 4.28% and a trailing twelve-month return on equity of 8.50%. The firm's quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $0.77 earnings per share.
View Addus HomeCare's earnings history

How has Addus HomeCare's stock price been impacted by COVID-19?

Addus HomeCare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ADUS shares have increased by 24.4% and is now trading at $84.16.
View which stocks have been most impacted by COVID-19

What price target have analysts set for ADUS?

1 brokers have issued twelve-month price targets for Addus HomeCare's stock. Their forecasts range from $115.00 to $115.00. On average, they expect Addus HomeCare's stock price to reach $115.00 in the next twelve months. This suggests a possible upside of 36.6% from the stock's current price.
View analysts' price targets for Addus HomeCare
or view top-rated stocks among Wall Street analysts.

Who are Addus HomeCare's key executives?

Addus HomeCare's management team includes the following people:
  • Mr. R. Dirk Allison, CEO & Chairman (Age 65, Pay $1.27M)
  • Mr. Brian W. Poff, CFO, Exec. VP, Sec. & Treasurer (Age 47, Pay $705.83k)
  • Mr. Sean P. Gaffney, Exec. VP & Chief Legal Officer (Age 41, Pay $476.5k)
  • Mr. David W. Tucker, Exec. VP & Chief Devel. Officer (Age 56, Pay $373.06k)
  • Mr. Michael D. Wattenbarger, Exec. VP & Chief Information Officer (Age 50, Pay $391.11k)
  • Mr. W. Bradley Bickham, Pres & COO (Age 58)
  • Ms. Monica Raines, Sr. VP & Chief Compliance Officer
  • Ms. Laurie Manning, Exec. VP & Chief Human Resource Officer (Age 65)
  • Mr. Darby Anderson, Exec. VP & Chief Strategy Officer (Age 55)
  • Ms. Diane Kumarich, Sr. VP of National Contracts & Bus. Devel.

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare CEO Dirk Allison on Dirk Allison has an approval rating of 51% among Addus HomeCare's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Addus HomeCare's key competitors?

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and The Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.30%), Dimensional Fund Advisors LP (3.57%), Ameriprise Financial Inc. (3.19%), Principal Financial Group Inc. (2.68%), Principal Financial Group Inc. (2.68%) and Price T Rowe Associates Inc. MD (2.55%). Company insiders that own Addus HomeCare stock include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham.
View institutional ownership trends for Addus HomeCare

Which major investors are selling Addus HomeCare stock?

ADUS stock was sold by a variety of institutional investors in the last quarter, including Polar Capital Holdings Plc, TimesSquare Capital Management LLC, Nuveen Asset Management LLC, Eaton Vance Management, Dimensional Fund Advisors LP, Royal Bank of Canada, Emerald Advisers LLC, and Emerald Mutual Fund Advisers Trust. Company insiders that have sold Addus HomeCare company stock in the last year include Brian Poff, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, and W Bradley Bickham.
View insider buying and selling activity for Addus HomeCare
or view top insider-selling stocks.

Which major investors are buying Addus HomeCare stock?

ADUS stock was bought by a variety of institutional investors in the last quarter, including Loomis Sayles & Co. L P, Ameriprise Financial Inc., BlackRock Inc., Brown Advisory Inc., Monarch Partners Asset Management LLC, Tygh Capital Management Inc., Kennedy Capital Management Inc., and Victory Capital Management Inc..
View insider buying and selling activity for Addus HomeCare
or or view top insider-buying stocks.

How do I buy shares of Addus HomeCare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $84.16.

How much money does Addus HomeCare make?

Addus HomeCare has a market capitalization of $1.34 billion and generates $764.78 million in revenue each year. The company earns $33.13 million in net income (profit) each year or $2.79 on an earnings per share basis.

How many employees does Addus HomeCare have?

Addus HomeCare employs 35,139 workers across the globe.

What is Addus HomeCare's official website?

The official website for Addus HomeCare is

Where are Addus HomeCare's headquarters?

Addus HomeCare is headquartered at 6801 GAYLORD PARKWAY, FRISCO TX, 75034.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]

This page was last updated on 6/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.